Global Med Technologies(R) Selected by St. Joseph's Healthcare System
April 24 2008 - 10:00AM
PR Newswire (US)
Northern New Jersey Center with 140-Year Quality Legacy Becomes
108th Site in Northeast Now Using Wyndgate Systems DENVER, April 24
/PRNewswire-FirstCall/ -- Global Med Technologies, Inc. (OTC:GLOB)
(BULLETIN BOARD: GLOB) , an international e-Health, medical
information technology company, today announced that its Wyndgate
Technologies(R) division has signed an agreement to license its
SafeTrace(R) donor management system to St. Joseph's Healthcare
System (St. Joseph's) located in Paterson, New Jersey. SafeTrace
will be used to monitor blood donations for St. Joseph's Regional
Medical Center's blood bank. Terms of the agreement were not
disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
Wyndgate's SafeTrace system will help St. Joseph's manage the
volume of information needed to successfully administer a large
healthcare system's blood bank, including donor scheduling, blood
product manufacturing and infectious disease testing. In addition,
SafeTrace will enable St. Joseph's to continue meeting the highest
standards in the industry -- such as the ISBT 128 blood component
labeling standard. Wm. Scott Dustin, Vice President of Sales and
Marketing for Wyndgate Technologies, commented, "After careful
research, St. Joseph's felt that Wyndgate's SafeTrace system was
the right software fit for their organization's complex needs. St.
Joseph's Healthcare System has a 140-year heritage of providing
quality care to the people of northern New Jersey regardless of
their ability to pay. We feel that our SafeTrace donor management
system will help St. Joseph's to further this legacy by helping to
streamline many of their critical processes, realize cost savings
from reduced waste and help to provide quality blood products to
their hospitals." About St. Joseph's Healthcare System Founded by
the Sisters of Charity of Saint Elizabeth in 1867, St. Joseph's
Regional Medical Center, a private, non-profit facility, is now the
hub of the multifaceted St. Joseph's Healthcare System. What began
as a 12-bed hospital is now a 792-bed academic tertiary medical
center and Level 2 Trauma Center staffed by more than 900 board
certified physicians. Also included in the system are St. Joseph's
Children's Hospital, a 120-bed state designated, full service
children's hospital, St. Joseph's Wayne Hospital, a 229-bed acute
care hospital, and St. Vincent's Nursing Home in Cedar Grove. From
102 patients in the first year of operation to more than 1.3
million patient visits in 2007, St. Joseph's continues to provide a
comprehensive spectrum of services designed to heal the minds,
bodies and spirits of those in need. About Global Med Technologies,
Inc. Global Med Technologies(R), Inc. is an international e-Health
medical information technology company providing information
management software products and services to the healthcare
industry. Its Wyndgate Technologies(R) division is a leading
supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers. Each
year, Wyndgate's products and services manage more than eight
million blood components, representing over 27% of the U.S. blood
supply. Wyndgate's products are also being used in Canada, Africa,
and the Caribbean. Wyndgate's software provides Vein-to-Vein(R)
tracking from donor collection to patient transfusion through its
Donor Doc(TM) interactive donor health history questionnaire,
ElDorado Donor(TM) and SafeTrace(R) donor management systems, to
its SafeTrace Tx(R) advanced transfusion management system. Global
Med's PeopleMed(R), Inc. subsidiary provides custom software
validation, consulting and compliance solutions to hospitals and
blood centers. PeopleMed's in-depth knowledge of Wyndgate's
products and the blood banking industry results in cost-effective
validation services, which leads to more efficient software
implementations and upgrades for our customers. For more
information about Global Med's products and services, please call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000, ; or investors, Paul Holm, President of
portfoliopr.inc, +1-212-888-4570, , for Global Med Technologies,
Inc. Web site: http://www.globalmedtech.com/
Copyright